EMB-driven glioblastoma multiforme progression via the MCT4/GPX3 axis: therapeutic inhibition by Ganxintriol A
Bo Cheng,
No information about this author
Jing Liu,
No information about this author
Ling Gao
No information about this author
et al.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 4, 2025
Embigin
(EMB)
is
a
transmembrane
glycoprotein
highly
expressed
in
glioblastoma
multiforme
(GBM),
yet
its
role
GBM
progression
remains
unclear.
In
this
study,
we
investigate
the
function
of
intracellular
EMB
promoting
and
evaluate
effect
Ganxintriol
A,
traditional
Chinese
herbal
extract,
treatment.
Bioinformatics
datasets
were
utilized
to
assess
expression
prognostic
value
patients.
vitro
experiments
such
as
PCR、western
blot,CCK8,transwell,wound
healing,clone
formation
flow
cytometry
assays
conducted
examine
EMB's
biological
functions
underlying
mechanisms
cell
lines.
Additionally,
constructed
subcutaneous
tumor
model
nude
mice
evaluated
medicine
extract
A
on
through
vivo
experiments.
associated
with
poor
prognosis
overexpression
accelerated
progression,
whereas
knockdown
had
opposite
effect.
Further
analysis
revealed
that
upregulated
epithelial-mesenchymal
transition
(EMT)
glycolysis
while
maintaining
glutathione
(GSH)
redox
balance
by
inducing
monocarboxylate
transporter
4
(MCT4)
peroxidase
3
(GPX3)
expression.
Treatment
significantly
downregulated
expression,
effectively
inhibiting
both
vivo.
This
study
highlights
an
independent
biomarker
for
reveals
novel
mechanism
which
drives
progression.
identified
promising
therapeutic
candidate
Language: Английский
Maximizing the Potential of Ketogenic Dieting as a Potent, Safe, Easy-to-Apply and Cost-Effective Anti-Cancer Therapy
Archives of Cancer Science and Therapy,
Journal Year:
2025,
Volume and Issue:
9(1), P. 001 - 005
Published: March 3, 2025
The
global
menace
of
cancer
requires
supplementary
treatments
beyond
standard
medical
approaches
for
effective
intervention.
Ketogenic
Diet
(KD)
composed
high
fats
combined
with
moderate
proteins
and
low
carbohydrates
has
become
popular
as
a
metabolic
therapy
cancer.
anti-cancer
mechanism
KD
works
through
stress
induction
in
cells,
reduced
insulin
IGF-1
signaling
pathways,
improved
mitochondrial
function,
inflammation,
immune
regulation.
Standard
receive
enhanced
outcomes
synergistic
action
which
simultaneously
decreases
treatment-related
side
effects.
To
achieve
optimized
treatment
cancer,
ketogenic
diet
practitioners
need
to
use
personalized
nutritional
planning
combination
tracking
exogenous
ketone
supplements.
It
is
essential
find
solutions
adherence
issues
nutrient
deficiencies
because
they
determine
KD’s
effectiveness
treatment.
fight
against
needs
sustained
multipronged
clinical
research
validation
establish
the
proper
implementation
this
method.
Language: Английский
Rethinking corticosteroids use in oncology
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 26, 2025
Corticosteroids
(CSs),
widely
used
in
oncology
for
their
anti-inflammatory
and
immunosuppressive
properties,
help
manage
cancer-related
symptoms
side
effects.
However,
long-term
use
may
negatively
affect
patient
survival
exacerbate
tumor
progression.
Elevated
glucose
glutamine
metabolism,
disruption
of
vitamin
D
levels,
alterations
the
microbiome
are
some
key
factors
contributing
to
these
adverse
outcomes.
Approaches
such
as
ketogenic
diets,
fasting,
sartans,
supplementation
have
shown
promise
providing
similar
benefits
CSs
while
mitigating
risks
associated
with
mechanisms
identified
This
perspective
underscores
necessity
a
reevaluation
cancer
care
advocates
further
research
into
safer,
more
effective
therapeutic
strategies.
Language: Английский
Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions
Cells,
Journal Year:
2025,
Volume and Issue:
14(7), P. 494 - 494
Published: March 26, 2025
Glioblastoma
(GBM)
is
the
most
aggressive
primary
brain
tumor
in
adults,
characterized
by
rapid
growth,
invasive
infiltration
into
surrounding
tissue,
and
resistance
to
conventional
therapies.
Despite
advancements
surgery,
radiotherapy,
chemotherapy,
median
survival
remains
approximately
15
months,
underscoring
urgent
need
for
innovative
treatments.
Key
considerations
informing
treatment
development
include
oncogenic
genetic
epigenetic
alterations
that
may
dually
serve
as
therapeutic
targets
facilitate
resistance.
Various
immunotherapeutic
strategies
have
been
explored
continue
be
refined
their
anti-tumor
potential.
Technical
aspects
of
drug
delivery
blood–brain
barrier
(BBB)
penetration
addressed
through
novel
vehicles
techniques
including
incorporation
nanotechnology.
Molecular
profiling
has
emerged
an
important
tool
individualize
where
applicable,
identify
patient
populations
with
sensitivity.
The
goal
this
review
describe
spectrum
potential
GBM
targets,
provide
overview
key
trial
outcomes.
Altogether,
progress
clinical
preclinical
work
must
critically
evaluated
order
develop
therapies
strongest
efficacy.
Language: Английский
Exploration of the multiomics-based mechanisms of Gancao Nourishing-Yin decoction in regulating mitochondrial metabolic genes CYB5R3 and PICK1 to influence glioma progression
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 8, 2025
Glioma
is
the
most
common
malignancy
of
central
nervous
system,
characterised
by
its
high
invasiveness
and
recurrence,
which
significantly
limit
therapeutic
outcomes.
Energy
metabolism
reprogramming,
especially
mitochondrial
dysfunction,
plays
a
pivotal
role
in
tumour
growth,
survival,
progression.
Mitochondria
serve
as
hub
for
energy
production
biosynthesis,
adapting
through
alterations
oxidative
phosphorylation,
lipid
metabolism,
tricarboxylic
acid
cycle
to
meet
metabolic
demands
gliomas.
Gancao
Nourishing-Yin
(GCNY)
decoction,
traditional
herbal
compound,
has
demonstrated
potential
antitumour
effects,
particularly
modulating
pathways
stress,
are
critical
cell
adaptation.
Genomic
data
from
glioma
GWAS
dataset
Finnish
R11
database
eQTL
13
distinct
brain
regions
were
analysed
using
Summary-data-based
Mendelian
Randomization(SMR)
identify
glioma-associated
genes.
MitoCarta3.0,
genes,
was
used
pinpoint
mitochondrial-related
Differentially
expressed
genes
(DEGs)
human
microglial
cells
treated
with
GCNY
extracted
GEO
GSE210945
cross-referenced
SMR
results
key
Colocalisation
analysis,
validation
TCGA
database,
survival
functional
annotations
performed
explore
mechanisms
action.
Integration
MitoCarta3.0
identified
19
linked
gliomas,
primarily
involved
amino
fatty
metabolism.
Among
these,
CYB5R3
PICK1
emerged
strong
genetic
links
signals
(PPH4
=
1).
CYB5R3,
upregulated
associated
enhanced
elevated
reactive
oxygen
species
(ROS)
production,
poor
outcomes
(HR
2.23,
P
<
0.001).
PICK1,
despite
being
downregulated,
showed
context-dependent
roles
progression,
expression
worse
prognosis
2.86,
moderate
predictive
capacity
one-year
(AUC
0.695).
This
study
highlights
identifying
regulators
influenced
GCNY.
By
pathways,
including
ROS
phosphorylation
activity,
offers
novel
multitarget
strategy
therapy.
These
findings
underscore
importance
target
gliomas
provide
new
insights
into
integrated
management.
Language: Английский
The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer
Thomas N. Seyfried,
No information about this author
Derek C. Lee,
No information about this author
Tomás Duraj
No information about this author
et al.
Journal of Bioenergetics and Biomembranes,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 8, 2025
Abstract
Otto
Warburg
originally
proposed
that
cancer
arose
from
a
two-step
process.
The
first
step
involved
chronic
insufficiency
of
mitochondrial
oxidative
phosphorylation
(OxPhos),
while
the
second
protracted
compensatory
energy
synthesis
through
lactic
acid
fermentation.
His
extensive
findings
showed
oxygen
consumption
was
lower
lactate
production
higher
in
cancerous
tissues
than
non-cancerous
tissues.
considered
both
and
extracellular
as
accurate
markers
for
ATP
OxPhos
glycolysis,
respectively.
Warburg’s
hypothesis
challenged
showing
remained
high
some
cells
despite
elevated
suggesting
largely
unimpaired.
New
information
indicates
neither
nor
are
surrogates
quantification
cells.
also
did
not
know
significant
amount
could
come
glutamine-driven
substrate
level
glutaminolysis
pathway
with
succinate
produced
end
product,
thus
confounding
linkage
to
origin
within
mitochondria.
Moreover,
new
shows
cytoplasmic
lipid
droplets
aerobic
fermentation
biomarkers
insufficiency.
original
can
now
be
linked
more
complete
understanding
how
underlies
dysregulated
cell
growth.
These
address
several
questionable
assumptions
regarding
allowing
field
advance
effective
therapeutic
strategies
less
toxic
metabolic
management
prevention
cancer.
Language: Английский